Status: Not yet recruiting
A Dose Optimization Study of Enzalutamide in Elderly Patients With Advanced Prostate Cancer
This is a phase II, single-centre, pragmatic, non-randomized, dose escalation study to evaluate optimal dose levels of enzalutamide in elderly patients using pharmacokinetic blood sampling concentrations.
Participants needed: 26
Trial details
Phase: Phase 2Age: 18+Biological sex: FemaleType: InterventionalSponsor: Sunnybrook Health Sciences CentreUpdated: Apr 6, 2026Locations: 1
Eligibility criteria
Male aged 75 years or older. [+11]
Metastatic castration-resistant prostate cancer [+12]